SCHEMBL11575368

SCHEMBL11575368

COc1ccc(CC(=NO)c2cc(OC)c(OC)cc2CC(=O)O)cc1OC

nearest known ligand 0.72

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ GAA P10253 6/20 0.72
▸ NPSR1 Q6W5P4 1/20 0.72
▸ CA5A P35218 1/20 0.50
▸ ALDH1A1 P00352 2/20 0.49
▸ TSHR P16473 1/20 0.49
▸ NFKB1 P19838 1/20 0.49
▸ TDP1 Q9NUW8 1/20 0.49
▸ KDM4E B2RXH2 1/20 0.46
▸ LMNA P02545 4/20 0.46
▸ HTT P42858 3/20 0.46
▸ SMN1; SMN2 Q16637 2/20 0.46
▸ HSD17B10 Q99714 1/20 0.46
▸ LDHA P00338 1/20 0.46
▸ KMT2A Q03164 3/20 0.45
▸ CYP1A2 P05177 1/20 0.45
▸ CYP3A4 P08684 1/20 0.45
▸ CYP2C19 P33261 1/20 0.45
▸ MAPK1 P28482 1/20 0.45
▸ NPC1 O15118 1/20 0.45
▸ MAPT P10636 2/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL11576174 0.84 GAA (1.00) GAANPSR1CA5AALDH1A1TSHR
SCHEMBL153055 0.79 GAA (0.74) GAANPSR1CA5AALDH1A1TSHR
SCHEMBL30049382 0.79 GAA (0.74) GAANPSR1CA5AALDH1A1TSHR
Hydrochloric Acid SCHEMBL2530820 0.77 GAA (0.72) GAANPSR1CA5AALDH1A1TSHR
SCHEMBL27952523 0.77 GAA (0.72) GAANPSR1CA5AALDH1A1TSHR
SCHEMBL25143507 0.76 MTNR1A (0.68) GAANPSR1CA5AALDH1A1TSHR
SCHEMBL30148026 0.76 MTNR1A (0.68) GAANPSR1CA5AALDH1A1TSHR
SCHEMBL7825089 0.74 GAA (0.76) GAANPSR1CA5AALDH1A1TSHR
SCHEMBL2339398 0.74 GAA (0.63) GAANPSR1ALDH1A1TSHRNFKB1
SCHEMBL21328347 0.73 CA5A (0.66) GAANPSR1CA5AALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-4075344-A 3-ALKOXYISOQUINOLINES FOR HYPOTENSIVE AND VASODILATING EFFECTS MEAD JOHNSON & COMPANY (US) 1978-02-21 — — US disclosed
US-4015006-A 3(2H)-Isoquinolones therapeutic process MEAD JOHNSON & COMPANY (US) 1977-03-29 — — US disclosed
Send feedback